Robert .0. Scagel has been productive in botanical research. His contributions to phycology have led to the following honours: Appointment as professor in botany and oceanography at the University of British Columbia; as summer session teacher in oceanography at the University of Washington; as representative of Canada and member of the Standing Committee on Oceanography in the Pacific Science Congress; and as one of the two chief researchers on algae in the present survey of the Indian Ocean from the Red Sea to the Cape of Good Hope, undertaken by the National Science Foundation of U.S.A.

Marlene Scardamalia’s theoretical, pedagogical and technological innovations have helped to create and shape a new field of inquiry: Knowledge Building. Knowledge Building engages students directly in the means by which knowledge in the world is advanced. Scardamalia’s award-winning research and development spanning a global network of hubs of innovation is making knowledge creation, previously reserved for a few, central to education for all students at all levels.

Marlene Scardamalia et ses innovations théoriques, pédagogiques et technologiques ont contribué à créer et à façonner un nouveau champ d’investigation : la construction du savoir. La construction du savoir engage directement les étudiants dans les moyens d’avancement des connaissances dans le monde. La recherche et le développement primés de Scardamalia, qui couvrent un réseau mondial de centres d’innovation, font de la création de connaissances, auparavant réservée à quelques-uns, un élément central de l’éducation pour les étudiants de tous les niveaux.

Dr. Schachter's major concern has been the biological synthesis, by enzymes (glycosyltransferases), of complex carbohydrates, important and unique components of all cell surfaces. He is a major figure in the field, through his research, his guidance of graduate students, and his lectures and written reviews. He was a pioneer with many unique contributions, including the first to localize these enzymes in the Golgi apparatus, thereby pointing to its important role in glycosylation, and the first to systematically isolate and characterize key glycosyltransferases (ten of them) involved in glycan branching and core synthesis, and to delineate the rules which control the synthesis of these highly complex structures. The biochemistry and molecular biology of these enzymes has since become a major field of study by his laboratory and others interested in the functions of complex carbohydrates and in the development of new therapeutic approaches to cancer metastasis, inflammation and other areas of medicine.

SCHAFER, Laurel - Department of Chemistry, The University of British Columbia Prof. Laurel Schafer has made seminal research contributions bridging the areas of organometallic and organic chemistry; she has developed a versatile ground-breaking new class of early transition metal complexes for use in selective carbon-nitrogen and carbon-carbon bond forming reactions of industrial relevance. These new catalytic systems synergistically minimise waste and maximise energy efficiency by utilising metals of low toxicity for sustainable approaches towards selective and specific chemical transformations.

John Scheffer has attained worldwide recognition for his pioneering research in the field of solid-state organic chemistry. Scheffer is the author of over 200 research publications and the recipient of a number of fellowships and awards, most recently the 2000 Alfred Bader Lecture Award of the Canadian Society for Chemistry.

Long Citation Stephen Scherer is one of Canada's leading geneticists making seminal contributions to the understanding of the human genome. He is internationally known for contributions to decoding the sequence of human chromosome 7, including the identification of 20 disease causing genes. His group also discovered the phenomena of large structural alterations as a common type of variation in the human genome contributing to both disease and evolution of chromosomes. He has published over 650 publications, won numerous awards including the Steacie Prize, a Howard Hughes Medical Institute Scholarship, the Premier’s Summit Award for Medical Research, the Killam Prize, and multiple Honorary degrees. Dr. Scherer is currently the Chief of Research at The Hospital for Sick Children (SickKids) in Toronto, Canada. Short Citation Stephen Scherer is an internationally known geneticists making seminal contributions to the understanding of the human genome. His group discovered the phenomena of large structural alterations as a common type of variation in the human genome contributing to both disease and evolution of chromosomes. Dr. Scherer has won numerous awards including the Steacie Prize, a Howard Hughes Medical Institute Scholarship, the Premier’s Summit Award for Medical Research, the Killam Prize, and multiple Honorary degrees. Dr. Scherer is currently the Chief of Research at The Hospital for Sick Children (SickKids) in Toronto, Canada.

Long Citation Ernesto Schiffrin is one of the great clinical scientists in Canada, and a world leader in the field of the mechanisms and management of arterial hypertension. Amongst many contributions, he demonstrated that anti-hypertensive drugs interfering with the renin-angiotensin-aldosterone system correct blood pressure and the structural remodeling of resistance arterioles, and he showed the role of endothelin in this vascular remodeling. Dr. Schiffrin brings together a profound knowledge of molecular and clinical medicine. His fundamental work has been recognized amongst many honours by his election as President of the American Heart Association Council for High Blood Pressure Research. Short Citation Ernesto Schiffrin is one of the great clinical scientists in Canada, and a world leader in the field of the mechanisms and management of arterial hypertension. Amongst many contributions, he demonstrated that anti-hypertensive drugs interfering with the renin-angiotensin-aldosterone system correct blood pressure and the structural remodeling of resistance arterioles. He also showed the role of endothelin in this vascular remodeling.

Dr. Aaron Schimmer is an international authority in cancer research focused on blood cancers known as leukemia. Through multiple pioneering discoveries, he has demonstrated how mitochondrial and metabolic pathways influence the development and progression of acute myeloid leukemia. As a clinician-scientist, he has translated these breakthroughs into the clinic by launching early phase clinical trials to evaluate new treatments for the disease.

Aaron Schimmer est une sommité internationale dans le domaine de la recherche sur les cancers sanguins, connus sous le nom de leucémies. Grâce à de nombreuses découvertes pionnières, il a démontré l’influence des voies mitochondriales et métaboliques sur le développement et la progression de la leucémie myéloïde aiguë. En tant que clinicien-scientifique, il a lancé des essais cliniques de phase précoce pour évaluer de nouveaux traitements de la maladie.

SCHLICH, Thomas – Social Studies of Medicine, McGill University Thomas Schlich is an eminent scholar in the history of modern surgery. His research has examined the rationale for surgery—why surgeons open the body—and the techniques they developed to do so—how they do it. Schlich’s work thus elucidates the history of medical innovation in its scientific, intellectual and social context, including organ transplants, metal implants in fracture treatment and minimally invasive surgery.

Thomas Schlich est un éminent chercheur en histoire de la chirurgie moderne. Ses recherches portent sur la logique de la chirurgie – les raisons pour lesquelles les chirurgiens ouvrent le corps – et sur les techniques développées à cette fin – les manières dont ils le font. Ses travaux éclairent ainsi l’histoire de l’innovation médicale dans ses contextes scientifique, intellectuel et social, y compris les transplantations d’organes, les implants métalliques dans le traitement des fractures et la chirurgie non effractive.

Louis Schmidt is the Science Research Chair in Early Determinants of Mental Health and a Pickering Award recipient. He is an internationally recognized expert in socioemotional development who has championed the importance of viewing personality development and developmental risk through individual, familial, and cultural lenses. His innovative interdisciplinary approach has transformed our understanding of socioemotional development across the lifespan, reduced stigma around mental illness, and challenged cultural stereotypes.

Louis Schmidt est titulaire de la chaire de recherche scientifique sur les déterminants précoces de la santé mentale et lauréat du prix Pickering. Il est un expert reconnu sur le plan international dans le domaine du développement socioémotionnel qui a défendu l’importance de considérer le développement de la personnalité et le risque de développement à travers un prisme individuel, familial et culturel. Son approche interdisciplinaire innovante a transformé notre compréhension du développement socioémotionnel tout au long de la vie, réduit la stigmatisation de la maladie mentale et remis en question les stéréotypes culturels.

Dr. M. Schnitzer is the leading world authority on soil organic matter, with emphasis on chemical structure of humic substances, mechanisms of interactions of humic materials with metals and minerals, and the isolation and identification of complex nitrogen compounds from soils. From extensive chemical and spectroscopic studies, he established a novel structural concept for humic materials. His research findings, embodied in 340 refereed papers and a textbook, have had an enormous impact on world agricultural production and environmental protection. In addition, he has edited two books and trained and inspired soil scientists worldwide. His contribution has been recognized by Fellowships in the CSSS, SSSA and the ASA, and the Wolf Prize in 1996.